| Just Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Real Estate > Home Sales Continue to Drop In Southern California |
|
Just Answers - Home Sales Continue to Drop In Southern California
Home sales are dropping in Southern California. For the fourth month in a row, home sales have continued to drop, According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product according to data for March. At the same time, the median price for a home in Southern California, has climbed abo ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ve the $500,000 mark. This is a divergence of trends. In the last several years home sales were robust and increas lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ing and so were home prices. Now home sales have slowed but prices are still inching upward in many areas. Home v here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe alues in Los Angeles, Orange, Riverside, San Diego and Ventura counties, increased 14% over one year ago. Homeowne d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro rs should not expect that rate of appreciation for the current year. In March the number of home sales fell almost ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc 10%. Sales activity is related to price activity. The fact that we are seeing a continuing series of months with easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi declining sales activity is an indicator that price activity is soon to follow. The current rate of home value app nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically reciation cannot be sustained in a climate of falling home sales. In Southern California the sales activity and th and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e rate of price increases reached a peak two years ago. In the current environment we are likely to see home value ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s rising at a much slower pace or even approaching 0. There are no indications that this is a real estate bubble ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a at this point, this is just a return to more normal market conditions. What we have seen in the past several years dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod is abnormal market conditions. The rapid growth in the real estate market must eventually return to a more normal cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin pace. When we see the number of home sales slow, especially for a multi month period, we can expect prices to lag tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen the slowdown in sales by around three months. We should see home appreciation start to really slow down soon in s t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel outhern California. Inventory is another factor of price. In this region inventory is increasing, but not at extr ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust aordinary levels. The time to sell a home is increasing. Last spring it was 27 days, now it is 48. The county to y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products watch is San Diego. It was the first county to accelerate in home value appreciation and the first to slow. It is . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de seen as a barometer for southern California. In the last six months median prices of homes in San Diego county hav elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e decreased 2%. This is not indicative of a bursting bubble, but an overheated market that is returning to normal. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:10 Steps To Regaining Control In The Work Place
|